MHUA Meihua Medical Technologies: Earnings per share for the last 12 months

MeihuaMed (MHUA) is a mature manufacturer of consumables in China currently modernizing its production of infusion systems. Growth is driven by expansion into the US and Europe, alongside the automation of its workshops. The company is implementing ESG environmental standards and strict bioethics. The annual volatility of TTM net income per share reflects the business dynamics, where the current value stands at -19.00, necessitating an assessment of impairment risks.
Financial and market metric breakdowns for MeihuaMed (MHUA)

MeihuaMed (MHUA) yield dynamics reflect the efficiency of global medical consumable supplies, where profit stability depends on wholesale shipment volumes from Chinese plants. By analyzing the percentage growth of earnings per share YoY over 12 months, an investor can discern the difference between current and previous annual EPS, allowing them to filter out market noise and assess the business's real expansion rate.